EUSTRALIS PHARMACEUTICALS LTD TRADING AS PRESSURA NEURO has a total of 42 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are DEVIREX AG, SOLVON ARZNEI VERTRIEB LIZENZ and THERANEXUS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | Australia | 6 | |
#4 | China | 4 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Brazil | 2 | |
#7 | Canada | 2 | |
#8 | Israel | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Singapore | 2 | |
#11 | Mexico | 1 | |
#12 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Vink Robert | 25 |
#2 | Vankan Pierre | 11 |
#3 | Willmbrink Grasiela Bourscheit | 10 |
#4 | Sasarman Andreea | 10 |
#5 | Robert Vink | 3 |
#6 | Pursey Peter | 1 |
#7 | Liakatos Angela | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021035289A1 | Therapeutic methods and uses thereof | |
WO2020132716A1 | Chemical compound manufacture, new salt form, and therapeutic uses thereof | |
US2020368226A1 | Parenteral Formulations And Uses Thereof | |
US2020368166A1 | Oral Formulations And Uses Thereof | |
KR20160029066A | Method for Preventing and/or Treating Chronic Traumatic Encephalopathy-II | |
US2016129007A1 | Method for Preventing and/or Treating Chronic Traumatic Encephalopathy - IV | |
SG11201509932XA | Method for preventing and/or treating chronic traumatic encephalopathy-i | |
WO2015000034A1 | Method for preventing and/or treating chronic traumatic encephalopathy-iii |